RYTM

113.0603.20%
JL

Jennifer Lee

Executive VP & Head of North America

Ms. Jennifer Lee serves as Executive Vice President and Head of North America at Rhythm Pharmaceuticals, Inc. since November 9, 2020. She served as Chief Commercial Officer at Krystal Biotech, Inc. since January 20, 2020 until October 16, 2020. Ms. Lee served as Vice President, Head of Genetic Diseases at Sanofi Genzyme from January 2017 to January 2020, where she was responsible for the U.S. commercial strategy and implementation for seven brands and launch presentation with rare diseases. During her tenure at Sanofi Genzyme, Ms. Lee also held leadership roles as Vice President, Head of Global Nephrological Diseases (November 2014 to January 2017), Senior Director of Global Marketing in Fabry disease, Senior Director of Global Market Access and International Marketing for the cardiovascular business, and Director of Business Development, in addition to leading business development efforts within various therapeutic areas. From November 2014 to January 2020, Ms. Lee held a variety of roles with increasing responsibility Sanofi Genzyme, a biotechnology company. She has extensive experience in rare diseases. Ms. Lee holds a bachelor’s of science degree from Massachusetts Institute of Technology and a master’s in public health (M.P.H.) from Harvard University.

Positions